Adoptive transfer from interferon-α-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-α secretion

Journal of Immunotherapy

Volumn 23, Issue 2, 2000, Pages 235-245

  Brod, Staley A ^a   Khan, Mohammed ^a   Nelson, Laura D ^a   Decuir, Brian ^a   Malone, Mike ^a   Henninger, Evelyn ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adoptive experimental autoimmune encephalomyelitis; Immunomodulators; Oral type I interferon; T cells TNF

Indexed keywords

ALPHA INTERFERON; CD8 ANTIGEN; CONCANAVALIN A; CYTIMMUNE; FREUND ADJUVANT; MYELIN BASIC PROTEIN; PERTUSSIS TOXIN; PROTEOLIPID PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DIET; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERFERON-ALPHA; MICE; MICE, INBRED STRAINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034117395     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200003000-00008     Document Type: Article

References (61)

1. Alvord EC, Shaw CM, Huby S, Kies MK. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression, and therapy. Ann NY Acad Sci 1965;122:333-45.
2. Raine CS, Stone SH. Animal models for multiple sclerosis: Chronic experimental allergic encephalomyelitis in inbred guinea pigs. N Y State J Med 1977;77:1693-6.
3. Wisnewski HM, Keith AB. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol 1977;1:144-8.
4. Feuer C, Prentice DE, Cammisuli S. Chronic relapsing experimental allergic encephalomyelitis in the lewis rat. J Neuroimmunol 1985;10:159-66.
5. Brod SA, Burns DK. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons. Neurology 1994;44:1144-8.
6. Brod SA, Scott M, Burns DK, Phillips JT. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons. J Interferon Cytokine Res 1995;15:115-22.
7. Brod SA, Khan M, Kerman RH, Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;58:61-9.
8. Lublin F. Adoptive transfer of murine relapsing experimental autoimmune encephalomyelitis. Ann Neurol 1985;17:188-90.
9. Peters BA, Hinrichs DJ. Passive transfer of experimental allergic encephalomyelitis in the Lewis rat with activated spleen cells: differential activation with mitogens. Cell Immunol 1982;69:175-85.
10. Lider O, Santos LMB, Lee CSY, Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 1989;142:748-52.
11. Diab A, Zhu J, Xiao B, Mustafa M, Link H. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J Neuropathol Exp Neural 1997;56: 641-50.
12. Issazadeh S, Lorentzen J, Mustafa M, et al. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J Neuroimmunol 1996;69:103-15.
13. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from EAE are asociated with downregulation of inflammatory cytokines and differential upregulation of TGF-b. J Exp Med 1992;176:1355-64.
14. Crisi G, Santambrogio L, Hochwald G, et al. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur J Immunol 1995; 25:3035-40.
15. Brown AM, McFarlin DE. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest 1981;45:278-84.
16. Miller SD, Clatch RJ, Pevear DC, Trotter JL, Lipton HL. Class II restricted T cell response in Theiler's murine encephalomyelitis virus induced demyelinating disease. J Immunol 1987;138:3776-84.
17. Lindsey J, Pappolla M, Steinman L. Reinduction of experimental autoimmune encephalomyelitis in mice. Cell Immunol 1995;162: 235-40.
18. Martin D, Near S, Bendele A, Russell D. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp Neurol 1995;131:221-8.
19. Renno T, Krakowski M, Piccirillo C, Lin L, Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 1995;154: 944-53.
20. Barten DM, Ruddle NH. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J Neuroimmunol 1994;51:123-33.
21. Selmaj K, Raine CS, Cross AH.Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694-700.
22. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-54.
23. Kim J, Woods A, Becker-Dunn E, Bottomly K. Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med 1985; 162:188-201.
24. Cher DJ, Mosmann TR. Two types of murine helper T cells. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987;138:3688-94.
25. Boom WH, Liano D, Abbas AK. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin-4 and interleukin-2 producing T cells clones on resting B cells. J Exp Med 1988;167: 1350-63.
26. Street N, Schumacher JH, Fong TAT, et al. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 1990;144:1629-37.
27. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR. Inflammatory leucocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL/J and B10.PL mice. Proc Natl Acad Sci USA 1992;89:574-8.
28. Brod SA, Benjamin D, Hafler DA. Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease. J Immunol 1991;147:810-5.
29. Haanen J, Malefijt R, Res R, et al. Selection of a human T helper type-1 T cell subset by Mycobacteria. J Immunol 1991;174:583-91.
30. Yssel H, Shanafelt M-C, Soderberg C, et al. Borrelia burgdorferai activates a T helper type-1 like T cell subset in Lyme arthritis. J Exp Med 1991;174:593-601.
31. McDonald AH, Swanborg RH. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis. J Immunol 1988;140:1132-8.
32. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveal that IL-10 mRNA expression correlates with disease. J Immunol 1992; 149:2496-2505.
33. Voorthuis JA, Uitdehaag BM, De Groot CJ, et al. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 1990;81:183-8.
34. Heremans H, Dillen C, Groenen M, Martens E, Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma. Eur J Immunol 1996;26:2393-8.
35. Duong TT, St. Louis J, Gilbert JJ, Finkelman FD, Strejan GH. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 1992;36:105-15.
36. Lublin FD, Knobler RL, Kalman B, et al.Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 1993;16:267-74.
37. Brod SA, Khan M.Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J Autoimmun 1996;9:11-20.
38. Karpus WJ, Swanborg RH. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-b. J Immunol 1991;146:1163-8.
39. Stevens D, Gould K, Swanborg R. Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J Neuroimmunol 1994;51:77-83.
40. Racke M, Sriram S, Carlino J, et al. Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2. J Neuroimmunol 1993;46:175-83.
41. Johns L, Sriram S. Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol 1993;47:1-7.
42. Bocci V. Is interferon effective after oral administration? J Biol Reg Homeostasis Agents 1990;4:81-3.
43. Bocci V. Catabolism of therapeutic proteins and peptides with implications for drug delivery. Adv Drug Del Rev 1990;4:149-69.
44. Bocci V. Absorption of cytokines via the oropharyngeal associated lymphoid tissues - Does an unorthodox route improve the therapeutic index of interferon. Clin Pharmacokinet 1991;21:411-17.
45. Bocci V. Immunomodulators as local hormones: new insights regarding their clinical utilization. J Biol Res Mod 1985;4:340-52.
46. Cantell K, Pyhala L. Circulating interferon in rabbits after administration by different routes. J Gen Virol 1973;20:97-104.
47. Hanley D, Wirowowska-Stewart M, Stewart W II. Pharmacology of interferons I. Pharmacologic distinctions between human leucocyte and fibroblast interferons. Int J Immunopharmacol 1979;1: 219-25.
48. Fleischmann WR, Koren S, Fleischmann CM. Oral administered interferons exert their white cell suppressive effects via a novel mechanism. Proc Soc Exp Biol Med 1992;201:199-207.
49. Gibson DM, Cotler S, Spiegel HE, Colburn WA. Pharmacokinetics of recombinant leucocyte A interferon following various routes and modes of administration to the dog. J Interferon Res 1985;5: 403-8.
50. Wills RJ, Spiegel HE, Soike KF. Pharmacokinetics of recombinant leucocyte A interferon following IV infusion and bolus, IM, and PO administration to african green monkeys. J Interferon Res 1984;4:399-409.
51. Witt PJ, Goldstein D, Storer BE, et al. Absense of biological effects of orally administered interferon-bser. J Interferon Res 1992; 12:411-13.
52. Goldstein D, Sielaff KM, Storer BE, et al. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-b serine. J Natl Cancer Inst 1989;81:1061-8.
53. Brod SA, Nelson L, Jin R, Wolinsky JS. Ingested IFN-a induces Mx mRNA. Cytokine 1998;11:492-9.
54. Brandtzaeg P. Overview of the mucosal immune system. Curr Topics Microbiol Immunol 1989;146:13-28.
55. Santos LMB, al-Sabbagh A, Londono A, Weiner HL. Oral tolerance to MBP induces TGF-b secreting T cell in Peyer's patch. J Immunol 1993;150(8,II):115A.
56. MacDonald TT. Immunosuppression caused by antigen feeding. II. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen. Eur J Immunol 1983;13:138-42.
57. Mattingly JA. Immunologic suppression after oral administration of antigen. Cell Immunol 1984;86:45-52.
58. Ford W, Gowan J. The traffic of lymphocytes. Semin Hematol 1969;6:67-83.
59. Butcher EC. The regulation of lymphocyte traffic. Curr Topics Microbiol Immunol 1986;128:85-122.
60. Butcher E, Picker L. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
61. Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS. Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis. Mult Scler 1997;3:1-7.